BRIEF published on 08/14/2026 at 10:32, 2 months 21 days ago Innate Pharma Announces €30 Million Share Offering Biotechnology Investment Share Offering Innate Pharma ADC Portfolio
PRESS RELEASE published on 08/14/2026 at 10:27, 2 months 21 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Innate Pharma prices €30 million offering of Ordinary Shares at €1.70 per share in Marseille, France. Proceeds will fund clinical development and ADC portfolio advancement Ordinary Shares Clinical Development Offering Innate Pharma ADC Portfolio
BRIEF published on 08/13/2026 at 22:05, 2 months 22 days ago Innate Pharma Launches €22.5 Million Share Offering Euronext Paris Clinical Development Share Offering Innate Pharma Institutional Buyers
PRESS RELEASE published on 08/13/2026 at 22:00, 2 months 22 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Innate Pharma announces proposed offering of ordinary shares worth approximately t €22.5 million, anchored by global coordinator Stifel, for continued clinical development and corporate purposes Ordinary Shares Clinical Development Offering Innate Pharma Stifel
BRIEF published on 08/10/2026 at 08:35, 2 months 25 days ago Innate Pharma Advances Lacutamab into Phase 3 Trial with Sobi Innate Pharma Lacutamab Phase 3 TELLOMAK-3 Markus Jensen Sobi Partnership
BRIEF published on 05/19/2026 at 07:05, 5 months 16 days ago Innate Pharma at the Jefferies Global Healthcare Conference Immunotherapy Cancer Innate Pharma Therapeutic Antibodies Jefferies Conference
BRIEF published on 05/19/2026 at 07:05, 5 months 16 days ago Innate Pharma to Attend Jefferies Global Healthcare Conference Biotechnology Cancer Treatment Immunotherapy Innate Pharma Jefferies Conference
PRESS RELEASE published on 05/19/2026 at 07:00, 5 months 16 days ago Inside Information / Other news releases Innate Pharma to participate in Jefferies Global Healthcare Conference on June 2-4, 2026 in New York, United States. Developing immunotherapies for cancer patients Biotechnology Innate Pharma Jefferies Global Healthcare Conference Immunothérapies Cancer Patients
BRIEF published on 04/17/2026 at 21:05, 6 months 17 days ago Innate Pharma presents interim results from the MATISSE trial at the AACR congress Lung Cancer Innate Pharma AACR 2026 IPH5201 Phase 2 MATISSE
BRIEF published on 04/17/2026 at 21:05, 6 months 17 days ago Innate Pharma Reveals Promising Interim Results in MATISSE Phase 2 Study Clinical Trials Lung Cancer Innate Pharma MATISSE Phase 2 IPH5201
Published on 11/04/2026 at 23:10, 5 hours 20 minutes ago Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 5 hours 30 minutes ago Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 6 hours 15 minutes ago Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 6 hours 25 minutes ago Stabilis Solutions Announces Third Quarter 2026 Results
Published on 11/05/2026 at 04:15, 15 minutes ago From Aba to Paris: Hearth Light Opens a New Chapter in International Intangible Cultural Heritage Exchange
Published on 11/05/2026 at 04:00, 30 minutes ago Andamanda Phuket: A Must-Visit Water Park for Family Holiday
Published on 11/05/2026 at 03:55, 35 minutes ago AlphaESS Named a BloombergNEF Tier 1 Energy Storage Manufacturer for the Fifth Consecutive Quarter in Q4 2026
Published on 11/05/2026 at 03:10, 1 hour 20 minutes ago SensAI Veritas Launches SensAI Gateway™ and SensAI Helm™: Bringing Risk Intelligence to the Moment of Trust
Published on 11/05/2026 at 00:02, 4 hours 28 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Share Raid by Goodman Group and Digital Realty
Published on 11/04/2026 at 18:00, 10 hours 30 minutes ago The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 17:44, 10 hours 46 minutes ago Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026
Published on 11/04/2026 at 11:56, 16 hours 33 minutes ago Mersen: Number of shares and voting rights as of October 31, 2026
